Do you have event related questions or need help with registration?
![]() |
Pharmacists and Pharmacy Technicians in all aspects of Pharmacy
|
|
Evaluate current evidence-based guidelines for the use of hormone replacement therapy in the management of perimenopausal and menopausal symptoms, including risks, benefits, and individualized patient considerations (P) |
|
|
List select medication that were newly approved by the FDA in 2025 (P/PT) |
|
|
Describe the dosing, precautions, common side effects, and key patient counseling points for these medications (P/PT) |
|
|
Apply recent guideline recommendations to clinical decision-making, including appropriate durations of DAPT (P) |
|
|
Identify types of coverage for GLP-1s including patient assistance programs (PAPs), insurance, manufacturer cash pay programs (P/PT) |
|
|
Interpret North Carolina Board of Pharmacy's position on compounded GLP-1s and practice explaining risks and benefits of these products to a patient (P) |
|
|
Describe lessons learned about barriers and facilitators for implementation of contraception services in community pharmacies (P) |
|
|
Identify pharmacologic and non-pharmacologic strategies for optimizing patient outcomes in perimenopause and menopause, with attention to contraindications, drug interactions, and counseling opportunities for pharmacists (P) |
|
|
Review the mechanism of action of the select medications and their role in their disease states (P/PT) |
|
|
Review the principles behind dual antiplatelet therapy (DAPT), including when it's indicated and which medications are used (P/PT) |
|
|
Utilize bleeding and thrombotic risk assessment tools to tailor DAPT to individual patient needs (P) |
|
|
Explain new criteria and indications for Medicaid coverage of GLP-1s for patients without diabetes (P) |
|
|
Discuss the uptake of pharmacist-prescribed hormonal contraception across North Carolina (P/PT) |
|
|
Develop workflows for providing contraception care for patients (P) |
Early Registration Fee- Pharmacists
$89.00Applies 11/7/25–12/8/25
Early Registration Fee- Pharmacy Techs
$59.00Applies 11/7/25–12/8/25
Registration Fee- Pharmacists
$104.00Applies 12/9/25–12/14/25
Registration Fee- Pharmacy Techs
$74.00Applies 12/9/25–12/14/25
The Mountain Area Health Education Center designates this entire live continuing education activity as meeting the criteria for 0.50 CEUs as established by the National Task Force on the Continuing Education Unit.
MAHEC designates this live continuing education activity as meeting the criteria for 5.00 Contact Hours.

The University Of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE program 0046-9999-25-286-L01-P/T provides 5.00 contact hours of continuing pharmacy education credit.
To receive CE credit, participants must verify attendance and complete the evaluation form(s) of this program. Participants must provide their name, email address, NABP e-Profile ID, and date of birth (MMDD) to receive credit. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.
It is the participant's responsibility to check CPE Monitor to verify credit has been uploaded. If credit is not shown, please contact the provider within 60 days of the program date. No partial session credit will be given.
12/14 8:00 AM – 1:30 PM
MAHEC has a pay-up-front policy for all CE programs. The only exceptions will be for pre-approved programs where an individual payment plan is appropriate. Registrations received without accompanying payment will not be processed and participants who have not paid the course fee will not be admitted into the program.
Unless otherwise noted in course materials, the following cancellation policy applies to all programs: